Literature DB >> 30090964

Isolation, characterization and efficacy of phage MJ2 against biofilm forming multi-drug resistant Enterobacter cloacae.

Muhsin Jamal1,2,3, Saadia Andleeb4,5, Fazal Jalil5,6, Muhammad Imran6,7, Muhammad Asif Nawaz7,8, Tahir Hussain9, Muhammad Ali8,10, Sadeeq Ur Rahman11,10, Chythanya Rajanna Das4,11.   

Abstract

Biofilm is involved in a variety of infections, playing a critical role in the chronicity of infections. Enterobacter cloacae is a biofilm-forming and multi-drug-resistant (MDR) nosocomial pathogen leading to significant morbidity and mortality. This study aimed at isolation of a bacteriophage against MDR clinical strain of E. cloacae and its efficacy against bacterial planktonic cells and biofilm. A bacteriophage MJ2 was successfully isolated from wastewater and was characterized. The phage exhibited a wide range of thermal and pH stability and demonstrated considerable adsorption to host bacteria in the presence of CaCl2 or MgCl2. Transmission electron microscopy (TEM) showed MJ2 head as approximately 62 and 54 nm width and length, respectively. It had a short non-contractile tail and was characterized as a member of the family Podoviridae [order Caudovirales]. The phage MJ2 was found to possess 11 structural proteins (12-150 kDa) and a double-stranded DNA genome with an approximate size of 40 kb. The log-phase growth of E. cloacae both in biofilm and suspension was significantly reduced by the phage. The E. cloacae biofilm was formed under different conditions to evaluate the efficacy of MJ2 phage. Variable reduction pattern of E. cloacae biofilm was observed while treating it for 4 h with MJ2, i.e., biofilm under static conditions. The renewed media with intervals of 24, 72, and 120 h showed biomass decline of 2.8-, 3-, and 3.5-log, respectively. Whereas, the bacterial biofilm formed with dynamic conditions with refreshing media after 24, 72, and 120 h demonstrated decline in growth at 2.5-, 2.6-, and 3.3-log, respectively. It was, therefore, concluded that phage MJ2 possessed considerable inhibitory effects on MDR E. cloacae both in planktonic and biofilm forms.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30090964     DOI: 10.1007/s12223-018-0636-x

Source DB:  PubMed          Journal:  Folia Microbiol (Praha)        ISSN: 0015-5632            Impact factor:   2.099


  6 in total

Review 1.  Pharmacologically Aware Phage Therapy: Pharmacodynamic and Pharmacokinetic Obstacles to Phage Antibacterial Action in Animal and Human Bodies.

Authors:  Krystyna Dąbrowska; Stephen T Abedon
Journal:  Microbiol Mol Biol Rev       Date:  2019-10-30       Impact factor: 11.056

Review 2.  Bacteriophage-Mediated Control of Biofilm: A Promising New Dawn for the Future.

Authors:  Cheng Chang; Xinbo Yu; Wennan Guo; Chaoyi Guo; Xiaokui Guo; Qingtian Li; Yongzhang Zhu
Journal:  Front Microbiol       Date:  2022-04-04       Impact factor: 6.064

Review 3.  Bacteriophage Therapy for Critical and High-Priority Antibiotic-Resistant Bacteria and Phage Cocktail-Antibiotic Formulation Perspective.

Authors:  Gursneh Kaur; Ritika Agarwal; Rakesh Kumar Sharma
Journal:  Food Environ Virol       Date:  2021-06-12       Impact factor: 2.778

4.  Characterization of the Three New Kayviruses and Their Lytic Activity Against Multidrug-Resistant Staphylococcus aureus.

Authors:  Natalia Łubowska; Bartłomiej Grygorcewicz; Katarzyna Kosznik-Kwaśnicka; Agata Zauszkiewicz-Pawlak; Alicja Węgrzyn; Barbara Dołęgowska; Lidia Piechowicz
Journal:  Microorganisms       Date:  2019-10-18

5.  Fungicidal Activity of AP10W, a Short Peptide Derived from AP-2 Complex Subunit mu-A, In Vitro and In Vivo.

Authors:  Yi Gong; Haoyi Li; Fei Wu; Yishuai Li; Shicui Zhang
Journal:  Biomolecules       Date:  2022-07-10

6.  Two Newly Isolated Enterobacter-Specific Bacteriophages: Biological Properties and Stability Studies.

Authors:  Martyna Cieślik; Marek Harhala; Filip Orwat; Krystyna Dąbrowska; Andrzej Górski; Ewa Jończyk-Matysiak
Journal:  Viruses       Date:  2022-07-12       Impact factor: 5.818

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.